U.S., May 8 -- ClinicalTrials.gov registry received information related to the study (NCT07572357) titled 'Clinical Evaluation of the RH210 Hearing Aid' on April 16.
Brief Summary: The RH210A is an air-conduction hearing aid designed for adults with perceived mild-to-moderate sensorineural hearing loss. The purpose of this clinical investigation is to generate objective and subjective evidence of the clinical performance and safety of the device.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Hearing Impairment, Sensorineural
Perceived Hearing Loss
Intervention:
DEVICE: Investigational device (RH210A)
Over the counter device
DEVICE: Apple AirPods Pro (2nd Generation) with Hearing Aid Feature (HAF)
FDA cleared ...